Answers are grounded in this paper and cite their sources.
There is an observed variation in the burden of hepatocellular carcinoma (HCC) across different US populations. Our study aims to comprehensively assess variations in HCC incidence and mortality rates across different regions of the US. Understanding these geographical differences is crucial, given prior evidence indicating variations in the incidence of viral hepatitis and metabolic dysfunction-associated steatotic liver disease and varying access to curative HCC treatment among states.
No takes yet. Share an insight, caveat, or question.
Abboud et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: